Jilin Aodong Pharmaceutical Group (000623.SZ) obtained 420 million yuan for repurchasing company shares to support financing.

12/11/2024

GMT Eight

Jilin Aodong Pharmaceutical Group (000623.SZ) announced that the company has received a loan commitment letter from Agricultural Bank of China Jilin Provincial Branch, with a loan amount of RMB 420 million specifically designated for stock repurchase.

On November 12th, a total of 319,850 Hong Kong dollars were spent to buy back 50,000 shares.

GLOBAL BIO-CHEM (00809) commences share repurchase program in accordance with the mandate granted

Contact: contact@gmteight.com

Jilin Aodong Pharmaceutical Group (000623.SZ) obtained 420 million yuan for repurchasing company shares to support financing.

RECOMMEND

ZHONGLIANG HLDG (02772) intends to appoint Zhonghui Anda as its new auditor.

CIRC(01763): The new production line for the second phase of Wuhan Gaoke Technetium-labeled drug has obtained the production license for radiopharmaceuticals.

GOLDEN RES DEV(00677) issues profit warning, expecting a shareholders' loss of approximately HK$4.6 million in the midterm, turning from a profit to a loss year-on-year.